SCHEMBL13009302

SCHEMBL13009302

c1ccc(-c2ccc(-c3c4ccc(N5c6ccccc6Cc6ccccc65)cc4c(-c4ccc(-c5ccccc5)cc4)c4ccc(N5c6ccccc6Cc6ccccc65)cc34)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.41
FAAH O00519 2/20 0.33
MGLL Q99685 2/20 0.33
HSD17B3 P37058 1/20 0.32
PDE6D O43924 1/20 0.32
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
CTDSP1 Q9GZU7 1/20 0.32
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
HRH1 P35367 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HSP90AA1 P07900 1/20 0.31
PKM P14618 1/20 0.31
HTT P42858 1/20 0.31
ATM Q13315 1/20 0.31
APP P05067 1/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13008790 1.00 HPGD (0.41) HPGDFAAHMGLLHSD17B3PDE6D
SCHEMBL13008988 0.97 HPGD (0.42) HPGDADRA2AADRA2BADRA2CCTDSP1
SCHEMBL13009389 0.97 HPGD (0.42) HPGDADRA2AADRA2BADRA2CCTDSP1
SCHEMBL13008233 0.93 HPGD (0.38) HPGDFAAHMGLLHSD17B3PDE6D
SCHEMBL13008186 0.92 ESR1 (0.37) HPGDFAAHMGLLHSD17B3PDE6D
SCHEMBL13009304 0.92 HPGD (0.39) HPGDFAAHMGLLHSD17B3PDE6D
SCHEMBL13008828 0.91 HSD17B3 (0.40) HPGDFAAHMGLLHSD17B3PDE6D
SCHEMBL13428100 0.91 HSD17B3 (0.40) HPGDFAAHMGLLHSD17B3PDE6D
SCHEMBL13426972 0.91 ESR1 (0.36) HPGDPDE6DALDH1A1HSP90AA1ESR1
SCHEMBL13426984 0.91 HPGD (0.35) HPGDPDE6DALDH1A1HSP90AA1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256176-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-12-01 EP disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A HPGD 4470/4885FAAH 3781/4885MGLL 4337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.